Search results for "Angina"

showing 10 items of 211 documents

PP-329 Menstrual Angina Improved after Trimetazidine Treatment in Middle Age Female

2014

Anginamedicine.medical_specialtybusiness.industryInternal medicinemedicineTrimetazidineCardiologyCardiology and Cardiovascular Medicinebusinessmedicine.diseaseMiddle agemedicine.drugThe American Journal of Cardiology
researchProduct

Anti-inflammatory and antioxidant effects of ranolazine on primary cultured astrocytes

2014

Because of its ability to block late INa [1], ranolazine is used as an antianginal agent for the treatment of chronic angina pectoris when angina is not adequately controlled by other agents [2]. Besides its cardiovascular effects, ranolazine improves different neuronal functions, and thus its use has been proposed for the treatment of pain and epileptic disorders [3,4]. Since astrocytes are involved in neuronal inflammatory processes, and autoimmune and neurodegenerative diseases [5], we have investigated the antiinflammatory and antioxidant effects of ranolazine in primary cultured astrocytes.

Antioxidantmedicine.drug_classbusiness.industrymedicine.medical_treatmentRanolazineChronic anginaPharmacologymedicine.diseaseCritical Care and Intensive Care MedicineAnti-inflammatoryAnginaPoster Presentationmedicinebusinessmedicine.drugCritical Care
researchProduct

Recanalization of Totally Occluded Coronary Vessels by Percutaneous Transluminal Coronary Angioplasty

1986

Since its introduction in 1977, percutaneous transluminal coronary angioplasty (PTCA) has become an effective approach for treatment of patients with single-vessel disease [1–3, 5]. Treatment of double- and multiple-vessel disease has also been attempted [5, 6]. In patients with angina pectoris total occlusion of coronary vessels is found, and PTCA has also been used in an attempt to restore coronary blood flow in such patients [8, 10]. Even main stem occlusions have been recanalized [11]. In patients with total occlusion of coronary vessels, collateral flow is sufficient to maintain cardiac function at rest but not during exercise [12–14]. Therefore, PTCA seems to be an ideal method for re…

Cardiac function curvePercutaneous transluminal coronary angioplastymedicine.medical_specialtybusiness.industryBlood flowmedicine.diseaseTotal occlusionAnginaCollateral flowInternal medicinemedicineCardiologyIn patientbusiness
researchProduct

[Diagnosis of coronary microvascualar dysfunction in diabetic patients with cardiac syndrome X: comparison by current methods].

2013

The study population included 208 patients with chest pain and uninjured coronary arteries that we split into two populations: diabetics (72 patients) and non-diabetics (136 patients). We split patients with chest pain and uninjured coronary arteries that had a myocardial scintigraphy into two populations: patients with positive scintigraphy and negative. We calculated, on angiographic images of each patient, stored on suitable digital supports, Timi Frame Count (TFC), Myocardial Blush Grade (MBG) and Total Myocardial Blush Score (TMBS) using the protocol described by Gibson and Yusuf. On the basis of Yusuf's experience we imagined a new index: the Total Timi Frame Count as the sum of the t…

Cardiac syndrome X chest pain coronary angiography diabetes mellitus microcirculation myocardial scintigraphyChest PainMicrocirculationReproducibility of ResultsCoronary DiseaseCoronary AngiographySeverity of Illness IndexElectrocardiographyPredictive Value of TestsRisk FactorsCoronary CirculationExercise TestHumansEmergency Service HospitalRadionuclide ImagingBlood Flow VelocityDiabetic AngiopathiesMicrovascular Angina
researchProduct

Langzeitverlauf über 10 Jahre nach Ballondilatation bei stabiler und instabiler Angina pectoris

2008

OBJECTIVE To assess the cardiac status of patients ten years after percutaneous transluminal coronary artery angioplasty (PTCA). PATIENTS AND METHODS Data of 534 patients (436 men, 98 women; mean age 53.2 +/- 8 years) in whom a PTCA had been performed between 1983 and 1986 were analysed, based on a questionnaire answered 121 +/- 11 months after the initial procedure. At the time of PTCA 184 patients (35%) had unstable angina, 350 (65%) stable angina. RESULTS 116 patients (63%) with unstable angina and 164 (47%) with stable angina had at least one cardiac event after the initial PTCA (repeat PTCA, bypass operation, myocardial infarction, death). None of these events occurred in 68 patients (…

Cardiovascular eventmedicine.medical_specialtyPercutaneousbusiness.industryUnstable anginaGeneral Medicinemedicine.diseasesurgical procedures operativeBypass operationInternal medicineCardiologyMedicineCoronary artery angioplastyIn patientcardiovascular diseasesMyocardial infarctionbusinessCardiac statusDMW - Deutsche Medizinische Wochenschrift
researchProduct

Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: a 20-year follow up

2013

BACKGROUND: Intima-media thickness (IMT) is a validated marker of preclinical atherosclerosis and a predictor of cardiovascular events. PATIENTS: We studied a population of 529 asymptomatic patients (age 62 ± 12.8 years), divided into two groups of subjects with and without Metabolic Syndrome (MetS). METHODS: All patients, at baseline, have had a carotid ultrasound evaluation and classified in two subgroups: the first one without atherosclerotic lesions and the second one with preclinical atherosclerosis (increased IMT or asymptomatic carotid plaque). Cardiovascular endpoints were investigated in a 20-years follow-up. RESULTS: There were 242 cardiovascular events: 144 among patients with Me…

Carotid Artery DiseasesMaleAsymptomatic carotid plaqueIntima-media thicknessEndocrinology Diabetes and MetabolismMyocardial InfarctionMyocardial IschemiaMetabolic syndrome Preclinical atherosclerosis Intima-media thickness Asymptomatic carotid plaque Cardiac event Cerebrovascular eventsCarotid Intima-Media ThicknessBody Mass IndexAortic aneurysmRisk FactorsPreclinical atherosclerosisLongitudinal StudiesUltrasonography Doppler ColorOriginal InvestigationAged 80 and overMetabolic Syndromeeducation.field_of_studySmokingMiddle AgedPlaque AtheroscleroticStrokeIschemic Attack TransientHypertensionCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicineAdultmedicine.medical_specialtyCardiac eventPopulationEndarterectomyRisk AssessmentAsymptomaticAngina PectorisDiabetes mellitusInternal medicinemedicineHumansObesityeducationAgedDyslipidemiasAngiologyCerebrovascular eventsAortic Aneurysm Thoracicbusiness.industrymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareCerebrovascular DisordersIntima-media thicknessAsymptomatic DiseasesMetabolic syndromebusinessBody mass index
researchProduct

Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month fol…

2008

Background The purpose of this study was to investigate whether the vasodilator response to brachial artery and the presence of carotid lesions may have a prognostic significance in patients with early stages of atherosclerosis. Methods and results Vascular echography was performed to analyze flow-mediated vasodilatation (FMD) at the brachial artery and intima–media thickness (IMT) of carotid arteries in 84 asymptomatic patients. At baseline, we evaluated all the established traditional cardiovascular risk factors. Transient ischemic attack, stroke, effort or unstable angina, acute myocardial infarction, peripheral arterial disease and cerebrovascular and cardiovascular death served as outc…

Carotid Artery DiseasesMalemedicine.medical_specialtyBrachial ArteryAsymptomaticCoronary artery diseaseSex FactorsRisk Factorsmedicine.arteryInternal medicineOdds RatiomedicineHumanscardiovascular diseasesMyocardial infarctionBrachial arteryStrokeAgedUltrasonographyCarotid atherosclerosis Endothelial dysfunction Prognosis Risk factorsUnstable anginabusiness.industryAge FactorsGeneral MedicineMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareVasodilationCarotid Arteriesmedicine.anatomical_structureBlood pressurecardiovascular systemCardiologyFemaleEndothelium Vascularmedicine.symptomTunica IntimaTunica MediaCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up StudiesArteryCoronary Artery Disease
researchProduct

Metabolic syndrome (MetS) predicts cardio and cerebrovascular events in a twenty years follow-up. A prospective study.

2012

BACKGROUND AND PURPOSE: Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors, considered as emerging and promoting atherosclerosis. This study aimed at the evaluation of the influence of MetS on the prediction of cerebro and cardiovascular events during a 20 years follow-up period in an asymptomatic population of middle-aged subjects. METHODS: We evaluated 529 asymptomatic persons through a prospective study. Study population was divided into two subgroups: patients with and without MetS. Echo-color-Doppler was used in order to assess the presence of subclinical atherosclerosis. A 20 years follow-up study was carried out in order to estimate the incidence of cerebro and car…

Carotid Artery DiseasesMalemedicine.medical_specialtyTime FactorsPopulationMetabolic syndrome cardiovascular cerebrovascular eventsKaplan-Meier EstimateAsymptomaticCarotid Intima-Media ThicknessRisk AssessmentDisease-Free SurvivalAnginaRisk FactorsInternal medicinemedicineOdds RatioPrevalenceHumansProspective StudiesProspective cohort studyeducationStrokeAgedProportional Hazards ModelsMetabolic Syndromeeducation.field_of_studyChi-Square Distributionbusiness.industryIncidence (epidemiology)IncidenceOdds ratioMiddle Agedmedicine.diseaseAtherosclerosisPrognosisSettore MED/11 - Malattie Dell'Apparato CardiovascolareEchocardiography Doppler ColorCerebrovascular DisordersItalyAsymptomatic DiseasesMultivariate AnalysisCardiologyFemaleMetabolic syndromemedicine.symptomCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesAtherosclerosis
researchProduct

Noninvasive evaluation of the celiac trunk and superior mesenteric artery with multislice CT in patients with chronic mesenteric ischaemia.

2008

This study sought to assess the role of multislice computed tomography (MSCT) in patients with suspected chronic mesenteric ischaemia (CMI). Forty-five patients (29 men; mean age 68) underwent MSCT angiography of the abdomen for suspected CMI (main clinical finding: postprandial abdominal pain). The scan protocol was detectors/collimation 16/0.75 mm; feed 36 mm/s; rotation time 500 ms; increment 0.4 mm; 120-150 mAs and 120 kVp. A volume of 80 ml of contrast material was administered through an antecubital vein (rate 4 ml/s), followed by 40 ml of saline (rate 4 ml/s). Images were analysed on the workstation with different algorithms (axial image scrolling, multiplanar reconstructions, maximu…

Chronic mesenteric ischaemiaAdultMalemedicine.medical_specialtychemical and pharmacologic phenomenacomplex mixturesAbdominal anginaCeliac ArteryIschemiaMesenteric Artery Superiormedicine.arteryparasitic diseasesMSCT angiographymedicineHumansRadiology Nuclear Medicine and imagingIn patientMesenterycardiovascular diseasesSuperior mesenteric arteryMSCT angiography Chronic mesenteric ischaemia Abdominal anginaAbdominal anginaNeuroradiologyAgedAged 80 and overmedicine.diagnostic_testbusiness.industryUltrasoundAngiographynutritional and metabolic diseasesInterventional radiologyGeneral MedicineMiddle Agedbacterial infections and mycosesChronic mesenteric ischaemiaTrunkdigestive system diseasessurgical procedures operativecardiovascular systemFemaleRadiologyCOMPUTED TOMOGRAPHYmedicine.symptombusinessTomography X-Ray Computedtherapeutics
researchProduct

Oral Glycoprotein IIb/IIa Antagonists for Unstable Angina — Is There Still a Chance for the Oral Substances?

2001

The intravenous glycoprotein IIb/IIIa antagonists abciximab, tirofiban and eptifibatide are well accepted for the therapy of patients with unstable angina and/or as concomitant medication during coronary interventions. Despite the fact that these drugs are not used in all patients presenting with unstable angina during coronary interventions, the scientific evidence is overwhelming including the substantial reduction in mortality 3 years after utilisation of abciximab for coronary interventions in patients with unstable angina. In addition to these two indications, intravenous glycoprotein IIb/IIIa antagonists are currently being investigated for use in patients undergoing carotid artery in…

Clinical Trials as Topicmedicine.medical_specialtyUnstable anginaFibrinogen receptorbusiness.industryAdministration OralPlatelet Glycoprotein GPIIb-IIIa ComplexHematologyTirofibanmedicine.diseaseAnginaInternal medicinemedicineAbciximabCardiologyEptifibatideHumansAngina UnstableMyocardial infarctionbusinessStrokePlatelet Aggregation Inhibitorsmedicine.drugThrombosis Research
researchProduct